These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30236540)

  • 21. Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling.
    Deep G; Gangar SC; Oberlies NH; Kroll DJ; Agarwal R
    Mol Carcinog; 2010 Oct; 49(10):902-12. PubMed ID: 20721970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
    Guerini V; Sau D; Scaccianoce E; Rusmini P; Ciana P; Maggi A; Martini PG; Katzenellenbogen BS; Martini L; Motta M; Poletti A
    Cancer Res; 2005 Jun; 65(12):5445-53. PubMed ID: 15958594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
    Debelec-Butuner B; Alapinar C; Varisli L; Erbaykent-Tepedelen B; Hamid SM; Gonen-Korkmaz C; Korkmaz KS
    Mol Carcinog; 2014 Feb; 53(2):85-97. PubMed ID: 22911881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha.
    Ko S; Shi L; Kim S; Song CS; Chatterjee B
    Mol Endocrinol; 2008 Feb; 22(2):273-86. PubMed ID: 17975021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity.
    Chaurasiya S; Widmann S; Botero C; Lin CY; Gustafsson JÅ; Strom AM
    PLoS One; 2020; 15(5):e0226057. PubMed ID: 32413024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling.
    Hu S; Li L; Yeh S; Cui Y; Li X; Chang HC; Jin J; Chang C
    Mol Oncol; 2015 Jan; 9(1):44-57. PubMed ID: 25135278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2-dependent matrix metalloproteinase-9 expression.
    Hwang YP; Yun HJ; Kim HG; Han EH; Choi JH; Chung YC; Jeong HG
    Toxicol Lett; 2011 May; 203(1):9-19. PubMed ID: 21354279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
    Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR
    Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-κB/MMP-9 signaling.
    Chen S; Liu W; Wang K; Fan Y; Chen J; Ma J; Wang X; He D; Zeng J; Li L
    PLoS One; 2017; 12(3):e0173725. PubMed ID: 28288190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total glucosides of paeony inhibits lipopolysaccharide-induced proliferation, migration and invasion in androgen insensitive prostate cancer cells.
    Zhang ZH; Xie DD; Xu S; Xia MZ; Zhang ZQ; Geng H; Chen L; Wang DM; Wei W; Yu DX; Xu DX
    PLoS One; 2017; 12(8):e0182584. PubMed ID: 28783760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
    Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW
    Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome.
    Malinen M; Niskanen EA; Kaikkonen MU; Palvimo JJ
    Nucleic Acids Res; 2017 Jan; 45(2):619-630. PubMed ID: 27672034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NF-kappaB regulates androgen receptor expression and prostate cancer growth.
    Zhang L; Altuwaijri S; Deng F; Chen L; Lal P; Bhanot UK; Korets R; Wenske S; Lilja HG; Chang C; Scher HI; Gerald WL
    Am J Pathol; 2009 Aug; 175(2):489-99. PubMed ID: 19628766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells.
    Lee SO; Lou W; Nadiminty N; Lin X; Gao AC
    Prostate; 2005 Jul; 64(2):160-7. PubMed ID: 15678501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.
    Liu PL; Tsai JR; Charles AL; Hwang JJ; Chou SH; Ping YH; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
    Mol Nutr Food Res; 2010 Jul; 54 Suppl 2():S196-204. PubMed ID: 20461740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piceatannol suppresses breast cancer cell invasion through the inhibition of MMP-9: involvement of PI3K/AKT and NF-κB pathways.
    Ko HS; Lee HJ; Kim SH; Lee EO
    J Agric Food Chem; 2012 Apr; 60(16):4083-9. PubMed ID: 22480333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-κB signaling in prostate cancer cells in vitro and in vivo.
    Liu YQ; Hu XY; Lu T; Cheng YN; Young CY; Yuan HQ; Lou HX
    PLoS One; 2012; 7(5):e38000. PubMed ID: 22666431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
    Hwang YS; Lee J; Zhang X; Lindholm PF
    Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer.
    McCarty MF; Hejazi J; Rastmanesh R
    Integr Cancer Ther; 2014 Sep; 13(5):386-95. PubMed ID: 24867960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymoquinone inhibits IL-7-induced tumor progression and metastatic invasion in prostate cancer cells by attenuating matrix metalloproteinase activity and Akt/NF-κB signaling.
    Alshyarba M; Otifi H; Al Fayi M; A Dera A; Rajagopalan P
    Biotechnol Appl Biochem; 2021 Dec; 68(6):1403-1411. PubMed ID: 33128273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.